CONTENT-ANALYSIS OF THE RUSSIAN MARKET OF SELECTIVE α2-ADRENOMIMETIC MEDICINAL DRUGS, APPLIED IN THERAPY OF RHINITIS OF DIFFERENT ETIOLOGY

Rhinitis of different etiology is a timely problem of contemporary otolaryngology.
Selective α2-adrenomimetics is one of the drug groups widely used in pharmacotherapy of these diseases. In large part these drugs belong to OTC-drugs, which makes the detailed discussion of pharmaceutic consulting issues very timely. Diversity of these drugs is a circumstance of no small importance, which creates some problems in formation of a rational range in pharmacy organizations. Considering all mentioned above, the marketing analysis of a market for further development of pharmaceutic
consulting algorithm, as well as methodic approaches to the formation of a rational range in pharmacy organizations is very timely. The purpose of the study: the analysis of the Russian market of selective α2-adrenomimetic medicinal drugs, applied in therapy of rhinitis of different etiology for detailed consideration of pharmaceutic
consultation issues and formation of a rational range. Materials and methods. During
the studies we carried out a content analysis base on the data from the State Register of Medicinal Drugs, and Register of Medicinal Drugs as of November 1, 2016. Results and discussion. As the result of the analysis we have established that Xylomethazoline was the leader of the Russian pharmaceutical market by the number of registered trade
names. The bigger part of the market is occupied by mono-preparations; nasal sprays
and nasal drops are dominant. The Russian market is represented mainly by the Russia
produced drugs. Naphthyzin, Nazivin, and Otrivin are the leaders by the number of information requests in RMD 2016 system. Conclusion. Followed by the results of the
studies we have obtained the date which can be used while developing the principles
and algorithm of pharmaceutical consulting, as well as for formation of rational
range of selective α2-adrenomimetic medicinal drugs, applied for therapy of rhinitis of
different etiology.

content-analysis, pharmaceutical market, range of medicinal drugs, α2-adrenomimetics (for rhinitis), state register of medicinal drugs

1. Ryazantsev S.V. Allergic rhinitis – etiology,pathogenesis, pharmacotherapy peculiarities: methodic recommendations, Saint Petersburg Research Institute of Ear, Throat, Nose, and Speech of the Federal Agency for Healthcare and Social Development. Saint Petersburg. 2006. P. 28. (in Russ.)

2. Pozdeeva M. Non-allergic rhinitis: types and treatment [text]. Katren Style, 2015, no. 12. P. 7–10. (in Russ.)

3. Yagudina R.I., Arinina E.E. School of Pharmacologist: rhinitis and ARVI. Russian Pharmacies, 2010, no. 4. P. 21–23. (in Russ.)

4. State Register of Medicinal Drugs [Electronic source]. Ministry of Healthcare of the Russian Federation, Access mode: http://grls.rosminzdrav.ru. (date of reference: 01.11.2016). (in Russ.)

5. Register of Medicinal Drugs [Electronic source]. Register of Medicinal Drugs of Russia System of guides, Access mode: http://www.rlsnet.ru. (date of reference: 01.11.2016). (in Russ.)